title: Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman.
authors.affiliation: Centro Regionale di Informazione sul Farmaco, AO Mater Domini, Catanzaro, Italy.
authors.forename: Christian
authors.initials: C
authors.lastname: Leporini
authors.forename: Antonio
authors.initials: A
authors.lastname: Rende
authors.forename: Alfonso
authors.initials: A
authors.lastname: Sorrentino
authors.forename: Elvira
authors.initials: E
authors.lastname: Rizzica
authors.forename: Emilio
authors.initials: E
authors.lastname: Russo
authors.forename: Luca
authors.initials: L
authors.lastname: Gallelli
authors.forename: Giovambattista
authors.initials: G
authors.lastname: De Sarro
mesh_terms: D000369:Aged, 80 and over; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D056687:Off-Label Use; D011134:Polysaccharides / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy*; D013927:Thrombosis / Q000139:chemically induced / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux
keywords: 4Ts score; Fondaparinux; HIT; HITT; nadroparin